John L. Marshall, MD, discusses the impact of the SUNLIGHT trial in patients with refractory metastatic colorectal cancer.

will support investigator-led projects exploring the potential of tipiracil/trifluridine (FTD/TPI) and futibatinib as therapeutic options for some of the most challenging cancer cases ...